pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,208 catalysts · 7,208 phase readout · 2,441 8k filing · 386 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: grant×type: recall×clear all
type
  • phase readout7,208
  • 8k filing2,441
  • earnings386
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›NOT_YET_RECRUITINGphase readoutNCT07564648: Impact of Novel vs. Usual Brand Menthol Cigarettes on Abuse Liability

Sponsor: Ohio State University Comprehensive Cancer Center. Phase: NA. Conditions: Cigarette Addiction, Tobacco Use Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT07630155: Office-Based Ureteroscopy Utilizing a Single Use Digital, Flexible Ureteroscope for Upper Tract Urothelial Carcinoma

Sponsor: University of Michigan Rogel Cancer Center. Phase: NA. Conditions: Renal Pelvis and Ureter Urothelial Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07731126: New Care Pathways for Supporting TRANSitional CARE From Hospital to Home Using AI and Personalized Digital Assistance

Sponsor: Istituto Nazionale di Ricovero e Cura per Anziani. Phase: NA. Conditions: Transitional Care, Remote Patient Monitoring (RPM), Geriatric Multimorbidity

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT04095026: Study of Direct Brain Recording and Stimulation for Memory Enhancement

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS). Phase: . Conditions: Epilepsy

full page →ctgov ↗
›COMPLETEDphase readoutNCT06492226: Study to Demonstrate Pharmacokinetic and Pharmacodynamic Similarity Between NKF-INS(A), US-NovoLog®, and EU-NovoRapid®

Sponsor: Xentria, Inc.. Phase: PHASE1. Conditions: Healthy Participants

full page →ctgov ↗
›RECRUITINGphase readoutNCT07328178: Analysis of the Role of IgE Proteoforms in Health and Disease

Sponsor: KU Leuven. Phase: . Conditions: Anaphylaxis, Mastocytosis, X-linked Agammaglobulinaemia, Venom Allergy, Chronic Spontaneous Urticaria (CSU), Type I Allergy, Medication Allergy, Healthy Control, Hereditary Alpha-Tryptasemia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07363278: A Prospective Observational Study Evaluating the Incidence of Silent Cerebral Lesions and Procedural Safety Following Atrial Fibrillation Ablation Using the VARIPULSE™ Pulsed Field Ablation System

Sponsor: Seoul National University Hospital. Phase: . Conditions: Atrial Fibrillation (AF)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07588243: A Clinical Study to Evaluate the Efficacy and Safety of Ultra in Promoting Hair Regrowth

Sponsor: CynosureLutronic. Phase: NA. Conditions: Androgenic Alopecia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07484815: Virtual Reality Intervention to Reduce Pain in Women Undergoing Elective Oocyte Cryopreservation

Sponsor: Hadassah Medical Organization. Phase: NA. Conditions: Procedure-Related Pain, Acute Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT06686615: A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

Sponsor: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company. Phase: . Conditions: Primary Hypercholesterolemiia, Mixed Dyslipidemia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07665515: Study of CryptiVax-1001 in Maintenance Setting for Advanced Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Sponsor: Epitopea Ltd. Phase: PHASE1. Conditions: Ovarian Cancer, HGSOC, HGS Ovarian, Fallopian Tube or Primary Peritoneal Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06204315: Risk Adapted Spinal Cord/Cauda Constraint Relaxation for High-risk Patients With Metastatic Epidural Spinal Cord Compression Undergoing Spine Stereotactic Radiosurgery

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Spinal Cord, Metastatic Epidural, Spine Stereotactic

full page →ctgov ↗
›COMPLETEDphase readoutNCT02878915: Ultrasound-guided Femoral Arterial Puncture for Interventional Neuro-radiology in Children

Sponsor: Fondation Ophtalmologique Adolphe de Rothschild. Phase: NA. Conditions: Retrograde Femoral Catheterism

full page →ctgov ↗
›COMPLETEDphase readoutNCT06076135: Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Solid Tumors

Sponsor: Chuangzhen Chen. Phase: PHASE2. Conditions: Metastatic Malignant Solid Neoplasm, Radiotherapy, Immune Checkpoint Blockade, Resistance to Immunotherapy

full page →ctgov ↗
›RECRUITINGphase readoutNCT06345508: Early Detection of Liver Cancer by QUS

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM). Phase: . Conditions: Hepatocellular Carcinoma, Liver Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07518225: Pre-Extubation Bupivacaine for Pain Control After Orthognathic Surgery

Sponsor: Esra Beyler. Phase: NA. Conditions: Postoperative Pain, Orthognathic Surgery

full page →ctgov ↗
›RECRUITINGphase readoutNCT06838676: ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

Sponsor: Nationwide Children's Hospital. Phase: PHASE2. Conditions: Diffuse Intrinsic Pontine Gliomas (DIPG), Progressive DIPG, Refractory DIPG, Recurrent DIPG, H3K27-altered High Grade Glioma

full page →ctgov ↗
›COMPLETEDphase readoutNCT06248476: Intermittent Theta Burst Stimulation and Repetitive Transcranial Magnetic Stimulation Combined With Robotic Rehabilitation on Ambulation in Spinal Cord Injury Patients

Sponsor: Gaziler Physical Medicine and Rehabilitation Education and Research Hospital. Phase: NA. Conditions: Spinal Cord Injuries

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07781176: Different Acupoint Stimulation for Postoperative Gastrointestinal Dysfunction in Primary Liver Cancer Patients

Sponsor: Shanghai Zhongshan Hospital. Phase: NA. Conditions: Primary Liver Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07716540: Analgesic Efficacy of Ultrasound-Guided Deep Iliacus Plane Block in Patients Undergoing Hip Fracture Surgery

Sponsor: Kanuni Sultan Suleyman Training and Research Hospital. Phase: NA. Conditions: Pain Management

full page →ctgov ↗
›TERMINATEDphase readoutNCT02860091: Blood Ropivacaine Concentrations Following Chest Wall Nerve Block Continuous Infusion

Sponsor: Boston Children's Hospital. Phase: . Conditions: Pain, Postoperative

full page →ctgov ↗
›COMPLETEDphase readoutNCT06978491: Evaluation of the Effect of Postoperative Analgesia Techniques With ObsQoR-10

Sponsor: Eskisehir Osmangazi University. Phase: NA. Conditions: Pain, Postoperative, Postoperative Complications

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07741591: Impact of Perioperative Antibiotic Use on Surgical Scarring

Sponsor: Nanfang Hospital, Southern Medical University. Phase: . Conditions: Surgical Scar, Postoperative Scar

full page →ctgov ↗
›TERMINATEDphase readoutNCT00780390: Autonomic Dysfunction and Spinal Cord Stimulation in Complex Regional Pain Syndrome

Sponsor: Vanderbilt University Medical Center. Phase: NA. Conditions: Complex Regional Pain Syndrome

full page →ctgov ↗
›TERMINATEDphase readoutNCT06502990: Open-label Study to Evaluate Metreleptin in Children Under 6 Years of Age With Generalised Lipodystrophy

Sponsor: Amryt Pharma. Phase: PHASE3. Conditions: Generalized Lipodystrophy

full page →ctgov ↗
›RECRUITINGphase readoutNCT07432490: A Phase II Study With Exploratory Outcomes of Fucose Supplementation in GLUT1 Deficiency Syndrome

Sponsor: Oregon Health and Science University. Phase: PHASE2. Conditions: Glut1 Deficiency, GLUT1DS1

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05229497: A Phase Ib/II Study of AK112 in Combination With AK117 in Advanced Malignant Tumors

Sponsor: Akeso. Phase: PHASE1. Conditions: Advanced Malignant Tumors

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06408597: Mannitol Versus Nitroglycerin for Kidney Injury Prevention in Robotic-assisted Radical Prostatectomy or Cystectomy

Sponsor: Nazmy Edward Seif. Phase: NA. Conditions: Prostate Cancer, Bladder Cancer, Surgery, Renal Impairment, Renal Injury, Acute

full page →ctgov ↗
›RECRUITINGphase readoutNCT05822609: Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes

Sponsor: University of Washington. Phase: PHASE2. Conditions: Diabetic Kidney Disease, Type 1 Diabetes

full page →ctgov ↗
›COMPLETEDphase readoutNCT05637099: The Value of Repeated BIOMarker Measurements During an SBT to Predict EXtubation Failure in ICU Patients

Sponsor: Henrik Endeman. Phase: . Conditions: Weaning Failure, Mechanical Ventilation, Spontaneous Breathing Trial, Extubation Failure

full page →ctgov ↗
›RECRUITINGphase readoutNCT07210632: Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)

Sponsor: Eben Rosenthal. Phase: EARLY_PHASE1. Conditions: Brain Cancer, HGG, Glioma, High Grade Glioma, High Grade Gliomas, High Grade Glioma (III or IV), High Grade Glioma (HGG) of the Brain With BRAF Aberration

full page →ctgov ↗
›RECRUITINGphase readoutNCT07625332: Pilot Study of Galantamine to Treat Metabolic Syndrome in People With Chronic Traumatic Spinal Cord Injury (SCI)

Sponsor: Northwell Health. Phase: PHASE2. Conditions: Spinal Cord Injury, Traumatic Spinal Cord Injury, Paraplegia and Tetraplegia, Metabolic Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT07261163: Obinutuzumab, Zanubrutinib, and Lenalidomide in First-line Treatment of Mantle Cell Lymphoma

Sponsor: Institute of Hematology & Blood Diseases Hospital, China. Phase: PHASE2. Conditions: Mantle Cell Lymphoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07453693: An Efficacy Study of a Dietary Supplement Drink Mix for Urinary Health Improvement

Sponsor: Bonafide Health. Phase: NA. Conditions: UTI's

full page →ctgov ↗
›COMPLETEDphase readoutNCT07770321: Effect of Audio-analgesia Using Binaural Beats and Instrumental Music on the Behaviour of Minimally Sedated Pediatric Patients

Sponsor: Rania Ahmedien. Phase: NA. Conditions: Behavior Management

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07720921: Neoadjuvant Disitamab Vedotin, Toripalimab, and Radiotherapy for High-risk UTUC ( LUXUS07.1 )

Sponsor: Peking University First Hospital. Phase: PHASE2. Conditions: Urothelial Carcinoma of the Renal Pelvis and Ureter, Neoadjuvant Therapy

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03449914: The GOLD Study: G8 in OLDer Patients

Sponsor: Istituto Oncologico Veneto IRCCS. Phase: . Conditions: Elderly Metastatic Colorectal Cancer Patients

full page →ctgov ↗
›COMPLETEDphase readoutNCT05698316: A Collaborative Resource of Heidelberg Multimodal Imaging of Intermediate and Early Atrophic AMD Cases to Study Prediction of Disease Progression

Sponsor: Association for Innovation and Biomedical Research on Light and Image. Phase: . Conditions: Age Related Macular Degeneration, Intermediate AMD, Atrophy, Prediction

full page →ctgov ↗
›COMPLETEDphase readoutNCT07296406: App-Based Self-Management for Somatic Symptom Disorder and MUS: A Pilot Study

Sponsor: Gangnam Severance Hospital. Phase: NA. Conditions: Somatic Symptom Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT06474806: Safety and Diagnostic Performance of uPAR PET Imaging in Localised, Untreated Prostate Cancer

Sponsor: Curasight. Phase: PHASE2. Conditions: Prostate Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07317206: Ayahuasca, Esketamine and PTSD

Sponsor: University of Sao Paulo. Phase: PHASE2. Conditions: Posttraumatic Stress Disorder (PTSD)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07417306: A Study of HDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor

Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.. Phase: PHASE3. Conditions: Type 2 Diabetes

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07671404: Cerebral Autoregulation and Delirium Study

Sponsor: University Health Network, Toronto. Phase: NA. Conditions: Delirium - Postoperative, Cardiac Surgery

full page →ctgov ↗
›COMPLETEDphase readoutNCT05330104: SENSE Study: Remote Symptom Monitoring for Patients With Chemotherapy-induced Peripheral Neuropathy

Sponsor: Allina Health System. Phase: NA. Conditions: Chemotherapy-induced Peripheral Neuropathy

full page →ctgov ↗
›RECRUITINGphase readoutNCT07297004: Stereotactic Body Radiation Therapy for Unresectable Locally Recurrent Rectal Cancer

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University. Phase: PHASE2. Conditions: Unresectable Locally Recurrent Rectal Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT06764784: The Efficacy of Freehand, Pilot Drilled and Fully Guided Implant Surgery in Partially Edentulous Patients: a Randomize Control Trial

Sponsor: King Khalid University. Phase: NA. Conditions: Partial Edentulism Class 1, Dental Implantation, Osseointegration

full page →ctgov ↗
›RECRUITINGphase readoutNCT07477184: Sleep Well Firefighters: An App-based Program to Improve Sleep, Cognition, and Behavioral Health in Firefighters

Sponsor: California Polytechnic State University-San Luis Obispo. Phase: NA. Conditions: Sleep Health, Stress, Anxiety, Physical Activity, Nutrition, Cognition

full page →ctgov ↗
›COMPLETEDphase readoutNCT07737652: Microcurrent Neurofeedback as an Adjunct to Standard Care for Substance Use Disorders

Sponsor: University of Alabama, Tuscaloosa. Phase: NA. Conditions: Depression, Anxiety, Substance Use Disorder (SUD), Post Traumatic Stress Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT07565649: Impact of Systematic Point-of-Care Ultrasound Implementation on Clinical Outcomes and Survival in Septic Shock: A Retrospective Single-Center Cohort Study

Sponsor: Clinica Universidad de Navarra, Universidad de Navarra. Phase: . Conditions: Septic Shock, Sepsis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06092749: Chronic Unilateral Lumbar Radicular Pain

Sponsor: Ain Shams University. Phase: NA. Conditions: Neuropathic Pain

full page →ctgov ↗
← prev
page 142 of 145
next →